In the last several years, Global market of Tissue Engineering developed rapidly, with an average growth rate of 18.76%. In 2016, Global Revenue of Tissue Engineering is nearly 11884.25 M USD. The major players in global Tissue Engineering market include Allergan Integra Lifesciences C. R. Bard Zimmer Biomet Organogenesis Osiris Therapeutics Cryolife ACell Biocomposites DSM Episkin J-TEC Athersys Biotime B. Braun International Stem Cell Bio Tissue Technologies Geographically, this report is segmented into several key Regions, with sales, revenue, market share and growth rate of Tissue Engineering in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Latin America India Others On the basis of product, the Tissue Engineering market is primarily split into Synthetic Materials Biologically Derived Materials Others On the basis on the end users/applications, this report covers Orthopedics, Musculoskeletal & Spine Neurology Cardiology & Vascular Skin & Integumentary Others
Table of Contents 1 Tissue Engineering Market Overview 1 1.1 Tissue Engineering Product Overview 1 1.2 Tissue Engineering Segment by Type (Product Category) 2 1.2.1 Classification of Tissue Engineering 2 1.2.2 Global Tissue Engineering Sales Market Share by Type in 2016 3 1.2.3 Synthetic Materials 3 1.2.4 Biologically Derived Materials 4 1.3 Global Tissue Engineering Segment by Applicati
